Delivery Order SPE2DR25D1201-SPE2DR26FAJTH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,131.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable rheumatoid arthritis medication. This firm fixed price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,452.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune conditions. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $59,112.32 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 31, 2025. The award is issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,950.67 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and was not subject to a set-aside designation. The contract was issued from AmerisourceBergen's corporate office in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL units. This competitively awarded, firm fixed price contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a widely used biologic medication for treating autoimmune conditions including rheumatoid arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $4,926.76 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used for autoimmune disease treatment. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, carries firm fixed pricing and was competitively awarded with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,510.60 and is scheduled for completion by July 1, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 80 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune diseases. The contract, awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJTHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,721.34 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a rheumatoid arthritis and autoimmune disease medication. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, under a firm fixed price arrangement. This delivery order is a non-set-aside competitive award issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor performing work at its corporate office location. The company holds a strategic role in the Defense Logistics Agency's medical supply chain, supporting critical pharmaceutical procurement needs for military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The SPE2DX vehicle under which this delivery order was issued encompasses a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains, enabling flexible fulfillment of federal healthcare requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 11/10/25 |